FasL expression and reverse signalling

Results and Problems in Cell Differentiation

Volumn 49, Issue , 2009, Pages 49-61

  Lettau, M ^a   Paulsen, M ^a   Kabelitz, D ^a   Janssen, O ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FASLG PROTEIN, HUMAN;

ANIMAL; BIOSYNTHESIS; CELL DEATH; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL DEATH; CELL SURVIVAL; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77649328967     PISSN: 00801844     EISSN: 18610412     Source Type: Book Series    
DOI: 10.1007/400_2008_21     Document Type: Article

References (37)

1. Badour K, Zhang J, Shi F, McGavin MK, Rampersad V, Hardy LA, Field D, Siminovitch KA (2003) The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity 18:141-154
2. Baum W, Kirkin V, Fernandez SB, Pick R, Lettau M, Janssen O, Zornig M (2005) Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J Biol Chem 280:40012-40024
3. Blott EJ, Bossi G, Clark R, Zvelebil M, Griffiths GM (2001) Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J Cell Sci 114:2405-2416
4. Boursalian TE, Fink PJ (2003) Mutation in fas ligand impairs maturation of thymocytes bearing moderate affinity T cell receptors. J Exp Med 198:349-360
5. Brunner T, Wasem C, Torgler R, Cima I, Jakob S, Corazza N (2003) Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin Immunol 15:167-176
6. Cahuzac N, Baum W, Kirkin V, Conchonaud F, Wawrezinieck L, Marguet D, Janssen O, Zornig M, Hueber AO (2006) Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 107:2384-2391
7. Cayabyab M, Phillips JH, Lanier LL (1994) CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol 152:1523-1531
8. Chitu V, Stanley ER (2007) Pombe Cdc15 homology (PCH) proteins: coordinators of membranecytoskeletal interactions. Trends Cell Biol 17:145-156
9. Desbarats J, Duke RC, Newell MK (1998) Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat Med 4:1377-1382
10. Frauwirth KA, Thompson CB (2002) Activation and inhibition of lymphocytes by costimulation. J Clin Invest 109:295-299
11. He JS, Ostergaard HL (2007) CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 179:2339-2348
12. Igney FH, Krammer PH (2005) Tumor counterattack: fact or fiction? Cancer Immunol Immunother 54:1127-1136
13. Janssen O, Sanzenbacher R, Kabelitz D (2000) Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 301:85-99
14. Janssen O, Qian J, Linkermann A, Kabelitz D (2003) CD95 ligand - death factor and costimulatory molecule? Cell Death Differ 10:1215-1225
15. Kirkin V, Cahuzac N, Guardiola-Serrano F, Huault S, Luckerath K, Friedmann E, Novac N, Wels WS, Martoglio B, Hueber AO, Zornig M (2007) The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ 14:1678-1687
16. Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532-542
17. Lettau M, Paulsen M, Kabelitz D, Janssen O (2008) Storage, expression and function of Fas Ligand, the key death factor of immune cells. Curr Med Chem 15(17):1684-1696
18. Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D, Janssen O (2006) The adaptor protein Nck interacts with Fas ligand: guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci USA 103:5911-5916
19. Lettau M, Schmidt H, Kabelitz D, Janssen O (2007) Secretory lysosomes and their cargo in T and NK cells. Immunol Lett 108:10-19
20. Lettau M, Qian J, Kabelitz D, Janssen O (2004) Activation-dependent FasL expression in T lymphocytes and Natural Killer cells. Signal Transduction 4:206-211
21. Li-Weber M, Krammer PH (2003) Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin Immunol 15:145-157
22. Linkermann A, Qian J, Lettau M, Kabelitz D, Janssen O (2005) Considering Fas ligand as a target for therapy. Expert Opin Ther Targets 9:119-134
23. Newell MK, Desbarats J (1999) Fas ligand: receptor or ligand? Apoptosis 4:311-315
24. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354-359
25. Qian J, Chen W, Lettau M, Podda G, Zornig M, Kabelitz D, Janssen O (2006) Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cell Signal 18:1327-1337
26. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323-370
27. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Watzl C, Kabelitz D, Leippe M, Janssen O (2008) 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics 8:2911-2925
28. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de SB, Janssen O, Saftig P (2007) ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14:1040-1049
29. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W (1995) Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507-521
30. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S (1995) Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813
31. Sun M, Ames KT, Suzuki I, Fink PJ (2006) The cytoplasmic domain of Fas ligand costimulates TCR signals. J Immunol 177:1481-1491
32. Sun M, Fink PJ (2007) A new class of reverse signaling costimulators belongs to the TNF family. J Immunol 179:4307-4312
33. Sun M, Lee S, Karray S, Levi-Strauss M, Ames KT, Fink PJ (2007) Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. J Immunol 179:5639-5643
34. Suzuki I, Fink PJ (1998) Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 187:123-128
35. Suzuki I, Martin S, Boursalian TE, Beers C, Fink PJ (2000) Fas ligand costimulates the in vivo proliferation of CD8+ T cells. J Immunol 165:5537-5543
36. Yang H, Reinherz EL (2006) CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST. J Immunol 176:5898-5907
37. Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, Bossi G, Griffiths GM (2007) Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 120:191-199